viernes, 14 de febrero de 2025

Targeting Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Available and Future Pharmaceutical Options.

https://read.qxmd.com/read/39897209/targeting-metabolic-dysfunction-associated-steatotic-liver-disease-masld-available-and-future-pharmaceutical-options?uac=148436CN&ecd=wnl_readmost_250214&sso=true&redirected=slug

No hay comentarios:

Publicar un comentario